Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CASSIE: Iluvien and Ranibizumab for Diabetic Macular Oedema
NCT03784443Phase 3Withdrawn
- Sponsor
- Imperial College London
- Start
- Sep 2019
- Primary completion
- Sep 2022
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of fluocinolone in diabetic macular edema (DME), sponsored by Imperial College London. Planned start Sep 2019; status: withdrawn.
02
Drugs
fluocinolone
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT03784443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03784443.